[
  {
    "text": "intellectual property",
    "id": "cp0.0",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "trade marks",
    "id": "cp0.1",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "applications for trade marks for the colour green as applied to service stations",
    "id": "cp0.2",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "amendments of applications and extent to which amendments substantially affected the identity of the trade mark and extended rights under registration for the purposes of s 65(2) and (5) of trade marks act 1995",
    "id": "cp0.3",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "use as a trade mark discussed",
    "id": "cp0.4",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "use of colour green not such as to establish distinctiveness for s 41(6) of trade marks act 1995",
    "id": "cp0.5",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "power of full court on appeal",
    "id": "cp0.6",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "trade marks",
    "id": "cp1.0",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "application for leave to appeal to full court from judgment of a single judge",
    "id": "cp1.1",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "opposition proceeding",
    "id": "cp1.2",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "where single judge ordered applications proceed to registration and marks subsequently registered",
    "id": "cp1.3",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "where no application for stay of single judge's orders",
    "id": "cp1.4",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "whether obligation to register marks after judgment on appeal from registrar's decision under s 68(1)(b)",
    "id": "cp1.5",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "whether full court has power to rectify register through cancellation or removal of marks pursuant to trade marks act , federal court of australia act or to preserve subject matter of appeal",
    "id": "cp1.6",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "exercise of discretion trade marks",
    "id": "cp1.7",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "colour mark",
    "id": "cp1.8",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "test under s 41(6)",
    "id": "cp1.9",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "whether determine full scope of mark when applying s 41(6)",
    "id": "cp1.10",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "test for leave to appeal in an opposition to registration",
    "id": "cp1.11",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "failure to consider matters raised",
    "id": "cp1.12",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "leave to appeal granted",
    "id": "cp1.13",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "practice and procedure",
    "id": "cp2.0",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "joinder of parties / party to be joined",
    "id": "cp2.1",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "appeal from decision of commissioner to rectify register of patents",
    "id": "cp2.2",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "party to be joined has no present cause of action",
    "id": "cp2.3",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "proceedings by party seeking to be joined for rectification in the event that the appeal is successful",
    "id": "cp2.4",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "no prejudice to applicant",
    "id": "cp2.5",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "application for joinder supported by commissioner",
    "id": "cp2.6",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "matters of law can adequately be dealt with by commissioner",
    "id": "cp2.7",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "matters of fact not able to be challenged by commissioner and can be addressed by party seeking to be joined",
    "id": "cp2.8",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "patents",
    "id": "cp3.0",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "patents regulations 1991",
    "id": "cp3.1",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "reg 10.7(7)",
    "id": "cp3.2",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "whether valid",
    "id": "cp3.3",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "whether ultra vires s 228 of the patents act 1990 (cth)",
    "id": "cp3.4",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "whether retrospective subordinate legislation",
    "id": "cp3.5",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "whether amendment of the register as required by reg 10.7(7) affects substantive rights of patentee, by reducing extended term of patent.",
    "id": "cp3.6",
    "type": "cited",
    "from": "[2006]"
  },
  {
    "text": "stevens v kabushiki kaisha sony computer entertainment  intellectual property",
    "id": "cp4.0",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "copyright",
    "id": "cp4.1",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "circumvention devices",
    "id": "cp4.2",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "circumvention of a technological protection measure",
    "id": "cp4.3",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "definition of \"technological protection measure\" in s 10(1) of the copyright act 1968 (cth) (\"the act \")",
    "id": "cp4.4",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "respondents produced and sold computer games on cd-roms for use with playstation consoles",
    "id": "cp4.5",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "access codes on the cd-roms could not be reproduced by conventional cd recording or copying devices",
    "id": "cp4.6",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "games could only be played if access codes were read by the boot rom device within a playstation console",
    "id": "cp4.7",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "appellant sold and installed \"mod chips\" into playstation consoles which allowed unauthorised copies of games to be played",
    "id": "cp4.8",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "whether appellant had knowingly sold or distributed a circumvention device which was capable of circumventing, or facilitating the circumvention of, a technological protection measure",
    "id": "cp4.9",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "whether access codes and boot rom were technological protection measures",
    "id": "cp4.10",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "whether access codes and boot rom prevented or inhibited the infringement of copyright by preventing access to unauthorised copies of games.  intellectual property",
    "id": "cp4.11",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "copyright",
    "id": "cp4.12",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "circumvention devices",
    "id": "cp4.13",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "literary works",
    "id": "cp4.14",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "computer programs",
    "id": "cp4.15",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "reproduction in a material form",
    "id": "cp4.16",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "definition of \"material form\" in s 10(1) of the act",
    "id": "cp4.17",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "parts of program code reproduced in the random access memory (\"ram\") of a playstation console as game is being played",
    "id": "cp4.18",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "whether access codes and boot rom prevented or inhibited the infringement of copyright in a literary work by preventing a substantial part of a computer program from being reproduced in ram",
    "id": "cp4.19",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "whether ram a \"material form\" for the purposes of the act .  intellectual property",
    "id": "cp4.20",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "copyright",
    "id": "cp4.21",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "circumvention devices",
    "id": "cp4.22",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "subject-matter",
    "id": "cp4.23",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "cinematograph films",
    "id": "cp4.24",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "part of the aggregate of visual images contained in program code copied in the ram of a playstation console as game is being played",
    "id": "cp4.25",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "whether access codes and boot rom prevented or inhibited the infringement of copyright in a cinematograph film by preventing a copy of the film being made in ram",
    "id": "cp4.26",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "whether a substantial part of a cinematograph film is embodied in ram as game is being played.  statutes",
    "id": "cp4.27",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "statutory construction",
    "id": "cp4.28",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "approach where provision is ambiguous",
    "id": "cp4.29",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "approach where provision is the product of legislative debate over evolving technology and compromise",
    "id": "cp4.30",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "use of extrinsic materials",
    "id": "cp4.31",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "relevance of legislative history",
    "id": "cp4.32",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "relevance of policy considerations",
    "id": "cp4.33",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "preference for interpretation which upholds fundamental rights.",
    "id": "cp4.34",
    "type": "cited",
    "from": "[2005]"
  },
  {
    "text": "[ database search ] [ name search ] [ recent decisions ] [ noteup ] [ lawcite ] [ help ] atlantis corporation pty ltd &amp; anor v peter schindler &amp; ors [1997] fca 455 (27 may 1997)   practice and procedure",
    "id": "cp7.0",
    "type": "cited",
    "from": "[1997]"
  },
  {
    "text": "appeal",
    "id": "cp7.1",
    "type": "cited",
    "from": "[1997]"
  },
  {
    "text": "stay of orders below revoking patent",
    "id": "cp7.2",
    "type": "cited",
    "from": "[1997]"
  },
  {
    "text": "principles on which granted",
    "id": "cp7.3",
    "type": "cited",
    "from": "[1997]"
  },
  {
    "text": "possible difficulty of rectifying register if appeal allowed",
    "id": "cp7.4",
    "type": "cited",
    "from": "[1997]"
  },
  {
    "text": "appropriate undertakings and conditions",
    "id": "cp7.5",
    "type": "cited",
    "from": "[1997]"
  },
  {
    "text": "federal court of australia act 1976 (cth) s 29",
    "id": "cp7.6",
    "type": "cited",
    "from": "[1997]"
  },
  {
    "text": "patents",
    "id": "cp8.0",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "validity",
    "id": "cp8.1",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "patent for (+)-enantiomer of the racemate, citalopram, and for method of obtaining that enantiomer",
    "id": "cp8.2",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "patentee also held previous patent for the racemate",
    "id": "cp8.3",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "both the racemate and the enantiomer, drugs for the treatment of depression",
    "id": "cp8.4",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "(+)-citalopram claimed to be therapeutically more effective than citalopram",
    "id": "cp8.5",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "challenge to validity of claim for (+)-citalopram",
    "id": "cp8.6",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "construction of claim",
    "id": "cp8.7",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "whether for (+)-enantiomer as an independently existing molecule or whether also for (+)-enantiomer when part of racemate",
    "id": "cp8.8",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "whether claim for (+)-enantiomer anticipated by patent for citalopram",
    "id": "cp8.9",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "whether (+)-enantiomer as an independent molecule was obvious",
    "id": "cp8.10",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "australian test for obviousness",
    "id": "cp8.11",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "application of that test to product claims for the (+)-enantiomer, and to method claim for the method of obtaining it",
    "id": "cp8.12",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "lack of utility",
    "id": "cp8.13",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "product claim for a dosage that, inter alia , was less than and more than a useful dosage range. held : (1) upon its proper construction, product claimed was the independently existing enantiomer; (2) the invention of the independently existing enantiomer was not anticipated by the patent for the racemate; (3) the australian \"matter of routine\" test for obviousness, when applied to the invention of the product, equated to the question whether those skilled in the art, as a matter of routine, would have had the goal of obtaining separate enantiomers in the expectation that one would be a desirable drug for the treatment of depression; (4) one of the product claims relating to dosage failed test of utility; (5) on the evidence, neither the (+)-enantiomer nor the method for obtaining it was obvious at the priority date.   patents",
    "id": "cp8.14",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "extension of term",
    "id": "cp8.15",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "patent for (+)-enantiomer of the racemate, citalopram, and for method of obtaining that enantiomer",
    "id": "cp8.16",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "patentee also held previous patent for the racemate",
    "id": "cp8.17",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "both the racemate and the enantiomer, drugs for the treatment of depression",
    "id": "cp8.18",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "(+)-citalopram claimed to be therapeutically more effective than citalopram",
    "id": "cp8.19",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "both cipramil (goods based on racemic citalopram) and lexapro (goods based on (+)-citalopram) entered in australian register of therapeutic goods (artg)",
    "id": "cp8.20",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "application for extension of term of patent for (+)-citalopram",
    "id": "cp8.21",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "commissioner of patents initially granted extension sought",
    "id": "cp8.22",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "subsequently, following hearing before her delegate, decided to reduce term of extension on ground that \"first regulatory approval date\" was date when goods cipramil based on racemate had been entered in artg",
    "id": "cp8.23",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "appeal by patentee",
    "id": "cp8.24",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "opponent pharmaceutical company contending that no extension at all should have been granted because application for extension had been made outside six month period following date of first inclusion in artg of goods containing the (+)-enantiomer, namely, cipramil, of which the active pharmaceutical substance was the racemate",
    "id": "cp8.25",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "questions of proper construction of patents act 1990 (cth) ss 70 , 71 , 77",
    "id": "cp8.26",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "whether goods based on racemate \"contain\" individual enantiomer",
    "id": "cp8.27",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "meaning of \"first regulatory approval date\" in s 70(5) of act. held : (1) cipramil contained pharmaceutical substance (+)-citalopram; (2) application for extension of term of patent had not been made within six months of first inclusion in artg of cipramil; (3) in circumstances, commissioner had lacked power to grant any extension to term of patent; (4) register of patents to be rectified by removal of particulars of extension.   patents",
    "id": "cp8.28",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "infringement",
    "id": "cp8.29",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "patent for (+)-enantiomer of the racemate, citalopram, and for method of obtaining that enantiomer",
    "id": "cp8.30",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "generic company applying to therapeutic goods administration (tga) for registration of generic drug based on (+)-enantiomer of citalopram",
    "id": "cp8.31",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "whether doctrine of \"mechanical equivalents\" or \"non-essential integers\" applicable to method of obtaining pharmaceutical compound",
    "id": "cp8.32",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "generic pharmaceutical company producing generic drug only for purpose of applying for regulatory approval",
    "id": "cp8.33",
    "type": "citing",
    "from": "[2008]"
  },
  {
    "text": "s 78(2) of patents act 1990 (cth).",
    "id": "cp8.34",
    "type": "citing",
    "from": "[2008]"
  }
]